Xencor (XNCR) Payables (2013 - 2026)
Xencor (XNCR) reported Payables of $7.9 million for Q1 2026, down 51.09% year-over-year from $16.2 million in Q1 2025, and down 26.87% quarter-over-quarter from $10.8 million in Q4 2025.
Xencor (XNCR) Payables (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Payables data on file, last reported at $7.9 million in Q1 2026.
- Payables for Q1 2026 came in at $7.9 million, down 51.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.9 million (down 51.09% YoY), and the FY2025 annual result was $10.8 million, down 35.39% from the prior year.
- Payables slipped to $7.9 million in Q1 2026 per XNCR's latest filing, from $10.8 million in the prior quarter.
- Over five years, Payables peaked at $18.8 million in Q3 2024 and troughed at $7.9 million in Q1 2026.
- A 5-year average of $14.2 million and a median of $15.0 million in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2025: Payables soared 121.41% in 2022, then sank 51.63% in 2025.
- A 5-year view of Payables shows it stood at $10.1 million in 2022, then jumped by 37.93% to $13.9 million in 2023, then gained by 20.45% to $16.8 million in 2024, then plunged by 35.39% to $10.8 million in 2025, then dropped by 26.87% to $7.9 million in 2026.
- Business Quant data shows XNCR's Payables at $7.9 million in Q1 2026, $10.8 million in Q4 2025, and $9.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 7.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.92 Mn |
| Dec 31, 2025 | 10.83 Mn |
| Sep 30, 2025 | 9.08 Mn |
| Jun 30, 2025 | 18.53 Mn |
| Mar 31, 2025 | 16.19 Mn |
| Dec 31, 2024 | 16.76 Mn |
| Sep 30, 2024 | 18.77 Mn |
| Jun 30, 2024 | 15.84 Mn |
| Mar 31, 2024 | 16.01 Mn |
| Dec 31, 2023 | 13.91 Mn |
| Sep 30, 2023 | 14.97 Mn |
| Jun 30, 2023 | 14.10 Mn |
| Mar 31, 2023 | 15.34 Mn |
| Dec 31, 2022 | 10.09 Mn |
| Sep 30, 2022 | 14.62 Mn |
| Jun 30, 2022 | 15.75 Mn |
| Mar 31, 2022 | 11.91 Mn |
| Dec 31, 2021 | 14.00 Mn |
| Sep 30, 2021 | 9.13 Mn |
| Jun 30, 2021 | 7.11 Mn |